Eam Investors, LLC Harvard Bioscience Inc Transaction History

Eam Investors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$4.19 - $6.16 $588,912 - $865,800	-140,552 Reduced 40.68%	204,994 $1.13 Million
Q1 2023 Jul 12, 2023	BUY	$2.45 - $4.22 $431,751 - $743,669	176,225 Added 104.08%	345,546 $1.45 Million
Q1 2023 May 12, 2023	BUY	$2.45 - $4.22 $414,836 - $714,534	169,321 New	169,321 $711,000
Q4 2021 Feb 11, 2022	SELL	$6.37 - $8.18 $1.09 Million - $1.4 Million	-170,580 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$6.98 - $8.47 $254,134 - $308,384	-36,409 Reduced 17.59%	170,580 $1.19 Million
Q1 2021 May 11, 2021	BUY	$3.91 - $6.99 $809,326 - $1.45 Million	206,989 New	206,989 $1.13 Million
Q4 2018 Feb 13, 2019	SELL	$3.03 - $5.0 $806,216 - $1.33 Million	-266,078 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$5.0 - $6.65 $770,020 - $1.02 Million	154,004 Added 137.41%	266,078 $1.4 Million
Q2 2018 Aug 03, 2018	SELL	$4.2 - $5.95 $85,940 - $121,748	-20,462 Reduced 15.44%	112,074 $600,000
Q1 2018 May 14, 2018	BUY	$3.3 - $5.15 $437,368 - $682,560	132,536 New	132,536 $663,000

31.5M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $87.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.